Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28439138
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Hosp+Pharm
2017 ; 52
(3
): 229-233
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Bezlotoxumab
#MMPMID28439138
Baker DE
Hosp Pharm
2017[Mar]; 52
(3
): 229-233
PMID28439138
show ga
Each month, subscribers to The Formulary Monograph Service receive 5 to 6
well-documented monographs on drugs that are newly released or are in late phase
3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees.
Subscribers also receive monthly 1-page summary monographs on agents that are
useful for agendas and pharmacy/nursing in-services. A comprehensive target drug
utilization evaluation/medication use evaluation (DUE/MUE) is also provided each
month. With a subscription, the monographs are available online to subscribers.
Monographs can be customized to meet the needs of a facility. Through the
cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in
this column. For more information about The Formulary Monograph Service, contact
Wolters Kluwer customer service at 866-397-3433. The March 2017 monograph topics
are crisaborole, insulin degludec/liraglutide, inclusion glargine/lixisenatide,
nusimersen, and rucaparib. The MUE is on insulin GLP-1 combo.